Fig. 3
From: Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
Crystal structures of dCK in complex with masitinib or imatinib. Section of the surface representation of the crystal structure of dCK in complex with UDP/masitinib (PDB ID: 5MQL) a and with UDP/imatinib (PDB ID: 5MQT) d. Detail of the interactions of masitinib (cyan) b and imatinib (green) e at the active site. Interactions with dCK mainly involve non-polar contacts. Overlay of masitinib c and imatinib f with gemcitabine (magenta) (PDB ID: 1P62) in the substrate binding site (cartoon representation)
